Nonylphenol disrupts the cardio-protective effects of 17β-estradiol on ischemia/reperfusion injury in isolated hearts of guinea pig

DOI Web Site Web Site PubMed 参考文献84件
  • Wang Yan
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China Department of Pharmacy, Beihai People’s Hospital, China
  • Hu Huiyuan
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Zhao Meimi
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Zhao Jinsheng
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Yin Dandan
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Sun Xuefei
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Liu Shuyuan
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Gao Qinghua
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China Department of Physiology, School of Basic Medical Sciences, China Medical University, China
  • Yu Lifeng
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China
  • Hao Liying
    Department of Pharmaceutical Toxicology, School of Pharmaceutical Sciences, China Medical University, China Cardiovascular Institute of China Medical University, China

この論文をさがす

抄録

Nonylphenol (NP), a widely distributed, toxic, endocrine-disrupting chemical, has estrogenic properties. However, its cardiac effects remain unclear. In this study, the effects of NP on isolated guinea pig hearts were studied in three separate experiments. First, hearts were perfused with 10-7 M NP or 10-5 M NP to determine whether NP was toxic to isolated healthy hearts. Next, hearts were subjected to 50 min of ischemia and 60 min of reperfusion (I50R60) with 10-7 M NP or 10-5 M NP to determine whether NP could aggravate ischemia/reperfusion (I/R) injury. Finally, the interaction of the cardio-protective agent 17β-estradiol (E2) with NP was studied using 10-7 M E2, 10-7 M E2 plus 10-7 M NP, and 10-7 M E2 plus 10-5 M NP. Heart rate (HR) and coronary flow (CF) were significantly decreased and the leakage of lactate dehydrogenase (LDH) in effluent was increased in the 10-5 M NP group. However, there were no obvious changes in HR, CF, the leakage of LDH or creatine kinase (CK), or the activity of superoxide dismutase in either of the NP treatments in the I50R60 model. Treatment with 10-7 M E2 attenuated I/R injury by increasing HR, decreasing the leakage of LDH and CK, and decreasing infarct size. However, these effects were reversed by both concentrations of NP. These data demonstrate that NP had direct toxic effects on normal hearts and NP might disrupt the cardio-protective effects of E2 on I/R injury.

収録刊行物

参考文献 (84)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ